BLOOMIN' BRANDS INC (BLMN)

US0942351083 - Common Stock

12.79  +0.2 (+1.59%)

After market: 12.79 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BLMN. BLMN was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of BLMN while its profitability can be described as average. BLMN is valued correctly, but it does not seem to be growing.



6

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
In the past year BLMN had a positive cash flow from operations.
BLMN had positive earnings in 4 of the past 5 years.
BLMN had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

BLMN has a worse Return On Assets (-0.15%) than 62.69% of its industry peers.
With a Return On Equity value of -2.18%, BLMN perfoms like the industry average, outperforming 50.75% of the companies in the same industry.
BLMN has a Return On Invested Capital of 8.45%. This is in the better half of the industry: BLMN outperforms 68.66% of its industry peers.
BLMN had an Average Return On Invested Capital over the past 3 years of 12.76%. This is above the industry average of 10.46%.
The last Return On Invested Capital (8.45%) for BLMN is well below the 3 year average (12.76%), which needs to be investigated, but indicates that BLMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.15%
ROE -2.18%
ROIC 8.45%
ROA(3y)5.61%
ROA(5y)3.13%
ROE(3y)65.87%
ROE(5y)-736.36%
ROIC(3y)12.76%
ROIC(5y)N/A

1.3 Margins

BLMN's Profit Margin has improved in the last couple of years.
The Operating Margin of BLMN (5.82%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BLMN has grown nicely.
The Gross Margin of BLMN (70.30%) is better than 85.07% of its industry peers.
In the last couple of years the Gross Margin of BLMN has remained more or less at the same level.
Industry RankSector Rank
OM 5.82%
PM (TTM) N/A
GM 70.3%
OM growth 3YN/A
OM growth 5Y11.58%
PM growth 3YN/A
PM growth 5Y15.33%
GM growth 3Y0.22%
GM growth 5Y0.35%

2

2. Health

2.1 Basic Checks

BLMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BLMN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BLMN has been reduced compared to 5 years ago.
BLMN has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.23, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BLMN (1.23) is comparable to the rest of the industry.
A Debt/Equity ratio of 4.54 is on the high side and indicates that BLMN has dependencies on debt financing.
The Debt to Equity ratio of BLMN (4.54) is worse than 60.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF N/A
Altman-Z 1.23
ROIC/WACC1.03
WACC8.22%

2.3 Liquidity

BLMN has a Current Ratio of 0.31. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN has a Current ratio of 0.31. This is amonst the worse of the industry: BLMN underperforms 89.55% of its industry peers.
A Quick Ratio of 0.22 indicates that BLMN may have some problems paying its short term obligations.
The Quick ratio of BLMN (0.22) is worse than 94.03% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.22

2

3. Growth

3.1 Past

The earnings per share for BLMN have decreased strongly by -23.59% in the last year.
Measured over the past years, BLMN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.33% on average per year.
Looking at the last year, BLMN shows a decrease in Revenue. The Revenue has decreased by -0.55% in the last year.
The Revenue has been growing slightly by 2.51% on average over the past years.
EPS 1Y (TTM)-23.59%
EPS 3YN/A
EPS 5Y14.33%
EPS Q2Q%-52.27%
Revenue 1Y (TTM)-0.55%
Revenue growth 3Y13.79%
Revenue growth 5Y2.51%
Sales Q2Q%-3.8%

3.2 Future

BLMN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.79% yearly.
BLMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.54% yearly.
EPS Next Y-27.14%
EPS Next 2Y-11.42%
EPS Next 3Y-4.79%
EPS Next 5YN/A
Revenue Next Year-4.43%
Revenue Next 2Y-0.78%
Revenue Next 3Y0.54%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

BLMN is valuated cheaply with a Price/Earnings ratio of 5.89.
BLMN's Price/Earnings ratio is rather cheap when compared to the industry. BLMN is cheaper than 98.51% of the companies in the same industry.
BLMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.96.
A Price/Forward Earnings ratio of 5.60 indicates a rather cheap valuation of BLMN.
Based on the Price/Forward Earnings ratio, BLMN is valued cheaply inside the industry as 97.76% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.82. BLMN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.89
Fwd PE 5.6

4.2 Price Multiples

BLMN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BLMN is cheaper than 91.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.55

4.3 Compensation for Growth

BLMN has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as BLMN's earnings are expected to decrease with -4.79% in the coming years.
PEG (NY)N/A
PEG (5Y)0.41
EPS Next 2Y-11.42%
EPS Next 3Y-4.79%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.15%, BLMN is a good candidate for dividend investing.
The stock price of BLMN dropped by -29.65% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
BLMN's Dividend Yield is rather good when compared to the industry average which is at 2.83. BLMN pays more dividend than 96.27% of the companies in the same industry.
BLMN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.23.
Industry RankSector Rank
Dividend Yield 7.15%

5.2 History

The dividend of BLMN is nicely growing with an annual growth rate of 21.41%!
BLMN has been paying a dividend for over 5 years, so it has already some track record.
The dividend of BLMN decreased recently.
Dividend Growth(5Y)21.41%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

BLMN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1570.91%
EPS Next 2Y-11.42%
EPS Next 3Y-4.79%

BLOOMIN' BRANDS INC

NASDAQ:BLMN (11/21/2024, 8:15:25 PM)

After market: 12.79 0 (0%)

12.79

+0.2 (+1.59%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.09B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 7.15%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 5.89
Fwd PE 5.6
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.41
Profitability
Industry RankSector Rank
ROA -0.15%
ROE -2.18%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.82%
PM (TTM) N/A
GM 70.3%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.31
Quick Ratio 0.22
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-23.59%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-27.14%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.55%
Revenue growth 3Y13.79%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y